Sanofi revenue decreased from €36.1 billion in 2019 to €36 billion in 2020, a (0.2%) decrease.

Annual Revenue ()

Sanofi revenue was €36.04 b in FY, 2020 which is a (0.2%) year over year decrease from the previous period.

FY, 2017FY, 2018FY, 2019FY, 2020
Revenue€35.06 b€34.46 b€36.13 b€36.04 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Sanofi revenue breakdown by business segment: 16.6% from Vaccines, 71.2% from Pharmaceuticals and 12.2% from Consumer Healthcare

Sanofi revenue breakdown by geographic segment: 39.0% from North America, 35.6% from Other Countries and 25.4% from Europe

FY, 2020FY, 2018FY, 2017FY, 2019
Vaccines€5.97 b€5.12 b€5.1 b€5.73 b
Pharmaceuticals€25.67 b€24.69 b€25.12 b€25.71 b
Consumer Healthcare€4.39 b€4.66 b€4.83 b€4.69 b
FY, 2020FY, 2018FY, 2017FY, 2019
Emerging Markets€10.11 b€10.26 b€10.91 b
Europe€9.15 b€9.43 b€9.53 b€8.85 b
United States€11.54 b€11.86 b€12.76 b
Rest of the World€3.38 b€3.42 b€3.6 b
North America€14.06 b
Other Countries€12.83 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu